Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry
Fabio Angeli(University of Insubria), Tiziana Bachetti(Istituti Clinici Scientifici Maugeri), Claudio Bruschi(Istituti Clinici Scientifici Maugeri), Michele Vitacca(Istituti Clinici Scientifici Maugeri), Laura Adelaide Dalla Vecchia(Istituti Clinici Scientifici Maugeri), Dina Visca(University of Insubria), Antonio Spanevello(Istituti Clinici Scientifici Maugeri), Piero Ceriana(Istituti Clinici Scientifici Maugeri), Egidio Traversi(Istituti Clinici Scientifici Maugeri), Francesca Perego(Istituti Clinici Scientifici Maugeri), Paolo Verdecchia(Azienda Ospedaliera di Perugia), Luca Chiovato(Istituti Clinici Scientifici Maugeri), Francesco Fanfulla(Istituti Clinici Scientifici Maugeri), Antonella Balestrino(Istituti Clinici Scientifici Maugeri), Simonetta Scalvini(Istituti Clinici Scientifici Maugeri), Maria Teresa La Rovere(Fondazione Salvatore Maugeri)
Cited by 18
Related Papers
European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring
|Journal of Hypertension|2013|1.4k
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
|European Journal of Internal Medicine|2020|1.3k
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring
|Journal of Hypertension|2014|1k
Noninvasive ventilation to prevent respiratory failure after extubation in high-risk patients*
|Critical Care Medicine|2005|553
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
|Hypertension|2004|506